Math Over Myth: Compass and Revive Release Phase 3 Updates but Stocks Drop
Math over Myth is your weekly source for psychedelic stock updates, including Compass Pathways and Revive Therapeutics
revive therapeutics
Psychedelic Business Spotlight: November 5
This week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher partners with Revive Therapeutics on microneedle patch technology; Mydecine patents nanotechnology.
Revive Therapeutics Is Exploring This Mushroom’s Potential to Treat Aggressive Breast Cancer
The company is also pursuing psilocybin as a possible treatment for rare cancers, but they see huge potential in researching the medicinal effects of the reishi mushroom.
End of content
End of content